Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?

International Angiology

Volumn 18, Issue 3, 1999, Pages 225-232

  Vicaretti, M ^a   Hawthorne, W ^a   Ao, P Y ^a   Fletcher, J P ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Blood vessel prosthesis adverse effects; Methicillin resistance; Prosthesis related infections; Staphylococcus aureus; Staphylococcus epidermidis

Indexed keywords

GELATIN; RIFAMPICIN;

ABSCESS; ANASTOMOSIS DEHISCENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DACRON IMPLANT; FEMALE; GRAFT INFECTION; INTERNAL CAROTID ARTERY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SHEEP; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOSIS; TREATMENT OUTCOME;

ANIMALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CAROTID ARTERY, COMMON; FEMALE; GELATIN; METHICILLIN RESISTANCE; POLYETHYLENE TEREPHTHALATES; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN; SHEEP; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0033452611     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Gelabert HA, Moore WS. The role of in situ graft replacement in abdominal aortic infections. In: Calligaro KD, Veith FJ, editors. Management of infected arterial grafts. St Louis: Quality Medical Publishing Incorporated, 1994:142-59.
2. Curl GR, Ricotta JJ. Total prosthetic graft excision and extra-anatomic bypass. In: Calligaro KD, Veith FJ, editors. Management of infected arterial grafts. St Louis: Quality Medical Publishing Incorporated, 1994:82-94.
3. Calligaro KD, Veith FJ, Schwartz ML, Savarese RP, Goldsmith J, Westcott CJ et al. Management of infected lower extremity autologous vein grafts by selective graft preservation. Am J Surg 1992;164:291-4.
4. Kieffer E, Bahnini A, Koskas F, Ruotolo C, Le Blevec D, Plissonier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: Results in forty three patients. J Vasc Surg 1993;17:349-56.
5. Clagett GP, Bowers BL, Lopez-Viago MA, Rossi MB, Valentine RJ, Myers SI et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg 1993;218:239-49.
6. Seeger JM, Wheeler JR, Gregory RT, Snyder SO, Gayle RG. Autogenous graft replacement of infected prosthetic grafts in the femoral position. Surg 1983;93:39-45.
7. Towne JB, Seabrook GR, Bandyk D, Freischlag JA, Edmiston CE. In situ replacement of arterial prosthesis infected by bacterial biofilms: Long-term follow-up. J Vasc Surg 1994;19:226-35.
8. Robinson JA, Johansen K. Aortic sepsis: Is there a role for in situ graft reconstruction? J Vasc Surg 1991;13:677-84.
9. Bandyk DF. In situ prosthetic graft replacement for coagulase-negative Staphylococci infection. In: Calligaro KD, Veith FJ, editors. Management of infected arterial grafts. St Louis: Quality Medical Publishing Incorporated, 1994:185-201.
10. Bandyk DF. Vascular graft infections: Epidemiology, microbiology, pathogenesis and prevention. In: Bernhard VM, Towne JB editors. Complications in vascular surgery. 3rd ed. St Louis: Quality Medical Publishing, 1991:223-34.
11. O'Brien T, Collin J. Prosthetic vascular graft infection. Br J Surg 1992;79:1262-7.
12. Avramovic JR, Fletcher JP. Rifampicin impregnation of a protein sealed Dacron graft: An infection resistant vascular graft. Aust N Z J Surg 1991;61:436-40.
13. Avramovic JP, Fletcher JP. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed dacron graft in combination with parenteral cephalosporin. J Cardiovasc Surg 1992;33:70-4.
14. Sardelic F, Peng PY, Fletcher JP. Development of a Staphylococcus epidermidis vascular graft infection model in sheep. Aust N Z J Surg 1995;65: 503-6.
15. Koneman EW, Allen SD, Dowell Jr VR, Sommers HM. Color atlas and textbook of diagnostic microbiology. Philadelphia: JB Lippincott Company, 1983.
16. Murray SP, Goldstone J. Diagnostic Advances. In: Calligaro KD, Veith FJ editors. Management of infected arterial grafts. St Louis: Quality Medical Publishing Incorporated, 1994:43-53.
17. Buckles JAC, Wilson SE. Prevention and management of prosthetic graft infection. In: Veith FJ, Hobson II RW, Williams RA, Wilson SE editors. Vascular surgery: principles and practice. 2nd ed. New York: McGraw-Hill Inc., 1994:1081-9.
18. Reilly LM, Stoney RJ, Goldstone J, Ehrenfield WK. Improved management of aortic graft infection. The influence of operation sequence and staging. J Vasc Surg 1987;5:421-31.
19. Ricotta JJ, Faggioli GL, Stella A, Curl GR, Peer P, Upson J et al. Total excision and extra-anatomic bypass for aortic graft infection. Am J Surg 1991;162:145-9.
20. Bandyk DF, Bergamini TM. Infection in prosthetic vascular grafts. In: Rutherford RB, editor. Vascular surgery. 4th ed. Philadelphia: WB Saunders Co., 1995:588-604.
21. Calligaro KD, Veith FJ, Schwartz ML, Savarese RP, DeLaurentis DA. Are Gram-negative bacteria a contraindication to selective preservation of infected vascular grafts. J Vasc Surg 1992;16:337-46.
22. Morris GE, Friend PJ, Vassallo DJ, Farrington M, Leapman S, Quick RG. Antibiotic irrigation and conservative surgery for major aortic graft infection. J Vasc Surg 1994;20:88-95.
23. Matley PJ, Beningfield SJ, Lourens S, Immelman EJ. Successful treatment of infected thoracoabdominal aortic graft by percutaneous catheter drainage. J Vasc Surg 1991;13:513-5.
24. Bailey IS, Hundred NJ, Pearson HJ, Bell PR. Successful treatment of an infected vascular graft with gentamicin beads. Eur J Vasc Surg 1987;1:143-4.
25. Reilley DT, Grigg MJ, Cunningham DA, Thomas EJ, Mansfield AO. Vascular graft infection: the role of indium scanning. Eur J Vasc Surg 1989;3:393-7.
26. Bunt TJ. Vascular graft infections: a personal experience. Cardiovasc Surg 1994;1:489-93.
27. Bergamini TM, Bandyk DF, Govostis D, Vetsch R, Towne JB. Identification of Staphylococcus epidermidis vascular graft infections. A comparison of culture techniques. J Vasc Surg 1989;9:665.
28. Becker R, Blundell P. Infected aortic bifurcation grafts: Experience with fourteen patients. Surg 1976; 80:544-9.
29. Ashton TR, Cunningham JD, Patan D, Maini R. Antibiotic loading of vascular grafts. Proceedings of the 16th Annual Meeting of the Society for Biomaterials 1990;13:235.
30. Chervu A, Moore WS, Gelabert HA, Colburn M, Chvapil M. Prevention of graft infection by use of prosthesis bonded with a rifampicin/collagen release system. J Vas Surg 1991;14:521-5.
31. Powell TW, Burnham SJ, Johnson G jr, A passive system using rifampicin to create an infection resistant vascular prosthesis. Surg 1983;94:765-9.
32. Schmitt DD, Bandyk DF, Pequet AJ, Towne JB. Bacterial adherence to vascular prostheses. A determinant of graft infectivity. J Vasc Surg 1986;3:732-40.
33. Bergamini TM, Bandyk DF, Govostis D, Kaebnick HW, Towne JB. Infection of vascular prostheses caused by bacterial biofilms. J Vasc Surg 1988;7:21-30.
34. Back MR, Klein SR. Infections and antibiotics in vascular surgery. In: White RA, Hollier LH, editors. Vascular surgery: Basic science and clinical correlations. Philadelphia: JB Lippincott Company, 1994: 613-24.
35. Naylor AR, Clark S, London NJ, Sayers RD, Macpherson DS, Barrie WW. Treatment of major aortic graft infection: preliminary experience with total graft excision and in situ replacement with a rifampicin bonded prostkesis. Eur J Endovasc Surg 1995;9:252-6.
36. Torsello G, Sandmann W, Gehrt A, Jungblut RM. In situ replacement of infected vascular prosthesis with rifampicin-soaked vascular grafts: Early results. J Vasc Surg 1993;17:768-73.